Dr. Zhang’s primary responsibility is product evaluation, in-licensing and development. He has broad experience in novel therapeutics, diagnostics and personalized medicine. With more than 30 years of R&D experience, Dr. Zhang held a senior position at Mitsubishi-Tanabe Pharma, where he led new technology acquisition, project management, biomarker and drug discovery for cancer, inflammation and metabolic diseases. He also served in multiple advisory roles, including at MediciNova. Dr. Zhang received his PhD in Biochemistry from the University of California at San Diego and completed postdoctoral training at the Salk Institute and Cold Spring Harbor Laboratory. Previously, he was an Assistant Fellow at the Institute of Genetics, Chinese Academy of Sciences. He holds an MS in Genetics from the Graduate School of the Chinese Academy of Sciences and a BS in Biology from Beijing Normal University.

Shawn Shao-Hui Zhang